- Home
- RVTY vs EHC Comparison
RVTY vs EHC Comparison
Compare RVTY & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | EHC |
|---|---|---|
| Founded | 1937 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Hospital/Nursing Management |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 10.7B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RVTY | EHC |
|---|---|---|
| Price | $86.44 | $101.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 7 |
| Target Price | $109.67 | ★ $143.29 |
| AVG Volume (30 Days) | 800.6K | ★ 833.7K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | 0.30% | ★ 0.74% |
| EPS Growth | N/A | ★ 24.22 |
| EPS | 2.07 | ★ 5.54 |
| Revenue | ★ $3,311,822,000.00 | N/A |
| Revenue This Year | $6.37 | $9.33 |
| Revenue Next Year | $5.10 | $8.14 |
| P/E Ratio | $45.82 | ★ $18.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $81.36 | $92.77 |
| 52 Week High | $118.30 | $127.99 |
Technical Indicators
Market Signals| Indicator | RVTY | EHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 44.26 |
| Support Level | $83.22 | $94.47 |
| Resistance Level | $88.60 | $109.21 |
| Average True Range (ATR) | 3.20 | 2.47 |
| MACD | 0.31 | -0.26 |
| Stochastic Oscillator | 29.76 | 7.85 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.